1887

Abstract

Although (HAV) is transmitted by the faecal–oral route, its target for replication is the liver. Little is known of its interactions with cells of the gastrointestinal tract, and it is not known by which mechanisms HAV crosses the intestinal epithelium. In this study, it is shown that HAV associated with IgA is translocated from the apical to the basolateral compartment of polarized epithelial cells via the polymeric immunoglobulin receptor by IgA-mediated reverse transcytosis. The relevance of this mechanism, by which HAV–IgA complexes may overcome the intestinal barrier and contribute to infections of the liver, results from the fact that HAV–IgA complexes are infectious for hepatocytes and that significant amounts of intestinal HAV–IgA are present during acute infections, which are also partly transmitted. Besides supporting the primary infection, this mechanism may play a role in relapsing infections by establishing an enterohepatic cycle for HAV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81157-0
2005-10-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/10/2747.html?itemId=/content/journal/jgv/10.1099/vir.0.81157-0&mimeType=html&fmt=ahah

References

  1. Asher L. V. S., Binn L. N., Mensing T. L., Marchwicki R. H., Vassell R. A., Young G. D. 1995; Pathogenesis of hepatitis A in orally inoculated owl monkeys ( Aotus trivirgatus ). J Med Virol 47:260–268 [CrossRef]
    [Google Scholar]
  2. Blank C. A., Anderson D. A., Beard M., Lemon S. M. 2000; Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J Virol 74:6476–6484 [CrossRef]
    [Google Scholar]
  3. Breitfeld P. P., Harris J. M., Mostov K. E. 1989; Postendocytotic sorting of the ligand for the polymeric immunoglobin receptor in Madin–Darby canine kidney cells. J Cell Biol 109:475–486 [CrossRef]
    [Google Scholar]
  4. Cuthbert J. A. 2001; Hepatitis A: old and new. Clin Microbiol Rev 14:38–58 [CrossRef]
    [Google Scholar]
  5. Dotzauer A., Feinstone S. M., Kaplan G. 1994; Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol 68:6064–6068
    [Google Scholar]
  6. Dotzauer A., Gebhardt U., Bieback K., Göttke U., Kracke A., Mages J., Lemon S. M., Vallbracht A. 2000; Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol 74:10950–10957 [CrossRef]
    [Google Scholar]
  7. Gan Y.-J., Chodosh J., Morgan A., Sixbey J. W. 1997; Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J Virol 71:519–526
    [Google Scholar]
  8. Glikson M., Galun E., Oren R., Tur-Kaspa R., Shouval D. 1992; Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine 71:14–23
    [Google Scholar]
  9. Heitmann A., Laue T., Schottstedt V., Dotzauer A., Pichl L. 2005; Occurrence of hepatitis A virus genotype III in Germany requires the adaptation of commercially available diagnostic test systems. Transfusion 45:1097–1105 [CrossRef]
    [Google Scholar]
  10. Hornei B., Kämmerer R., Moubayed P., Frings W., Gauss-Müller V., Dotzauer A. 2001; Experimental hepatitis A virus infection in guinea pigs. J Med Virol 64:402–409 [CrossRef]
    [Google Scholar]
  11. Kaetzel C. S., Robinson J. K., Chintalacharuvu K. R., Vaerman J.-P., Lamm M. E. 1991; The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A 88:8796–8800 [CrossRef]
    [Google Scholar]
  12. Karayiannis P., Jowett T., Enticott M., Moore D., Pignatelli M., Brenes F., Scheuer P. J., Thomas H. C. 1986; Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver cell damage. J Med Virol 18:261–276 [CrossRef]
    [Google Scholar]
  13. Karayiannis P., McGarvey M. J., Fry M. A., Thomas H. C. 1988; Detection of hepatitis A virus RNA in tissues and faeces of experimentally infected tamarins by cDNA-RNA hybridisation. In Viral Hepatitis and Liver Disease pp  117–120 Edited by Zuckerman A. J. New York: Wiley–Liss;
    [Google Scholar]
  14. Locarnini S. A., Coulepis A. G., Kaldor J., Gust I. D. 1980; Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy. J Clin Microbiol 11:710–716
    [Google Scholar]
  15. Lofgren B., Nordenfelt E., Jonsson S., Kronvall G. 1980; New bacterial absorption method for determination of hepatitis A IgM and IgA antibodies. J Med Virol 6:37–44 [CrossRef]
    [Google Scholar]
  16. Mestecky J., Lue C., Russell M. W. 1991; Selective transport of IgA. Cellular and molecular aspects. Gastroenterol Clin North Am 20:441–471
    [Google Scholar]
  17. Mostov K. E. 1994; Transepithelial transport of immunoglobulins. Annu Rev Immunol 12:63–84 [CrossRef]
    [Google Scholar]
  18. Mostov K. E., Deitcher D. L. 1986; Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 46:613–621 [CrossRef]
    [Google Scholar]
  19. Naudet G. C. 1988; Entwicklung einer Methode zum Nachweis von IgA-Antikörpern gegen das Hepatitis A-Virus und Verlauf des Antikörpertiters im Serum . PhD thesis Medical Faculty of the University of Tübingen, Germany (in German);
  20. Normann A., Jung C., Vallbracht A., Flehmig B. 2004; Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J Med Virol 72:10–16 [CrossRef]
    [Google Scholar]
  21. Ouzilou L., Caliot E., Pelletier I., Prévost M.-C., Pringault E., Colbère-Garapin F. 2002; Poliovirus transcytosis through M-like cells. J Gen Virol 83:2177–2182
    [Google Scholar]
  22. Ping L.-H., Lemon S. M. 1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 66:2208–2216
    [Google Scholar]
  23. Rojas R., Apodaca G. 2002; Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol 3:944–955 [CrossRef]
    [Google Scholar]
  24. Schiff E. R. 1992; Atypical clinical manifestations of hepatitis A. Vaccine 10 (Suppl. 1):S18–S20 [CrossRef]
    [Google Scholar]
  25. Shimada S., Kawaguchi-Miyashita M., Kushiro A. 8 other authors 1999; Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J Immunol 163:5367–5373
    [Google Scholar]
  26. Sikuler E., Keynan A., Hanuka N., Friedman M. G., Sarov I. 1983; Detection and persistence of specific IgA antibodies in serum of patients with hepatitis A by capture radioimmunoassay. J Med Virol 11:287–294 [CrossRef]
    [Google Scholar]
  27. Silvey K. J., Hutchings A. B., Vajdy M., Petzke M. M., Neutra M. R. 2001; Role of immunoglobulin A in protection against reovirus entry into murine Peyer's patches. J Virol 75:10870–10879 [CrossRef]
    [Google Scholar]
  28. Stapleton J. T., Lange D. K., LeDuc J. W., Binn L. N., Jansen R. W., Lemon S. M. 1991; The role of secretory immunity in hepatitis A virus infection. J Infect Dis 163:7–11 [CrossRef]
    [Google Scholar]
  29. Tomana M., Phillips J. O., Kulhavy R., Mestecky J. 1985; Carbohydrate-mediated clearance of secretory IgA from the circulation. Mol Immunol 22:887–892 [CrossRef]
    [Google Scholar]
  30. Tomana M., Kulhavy R., Mestecky J. 1988; Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762–770
    [Google Scholar]
  31. Yoshizawa H., Itoh Y., Iwakiri S., Tsuda F., Nakano S., Miyakawa Y., Mayumi M. 1980; Diagnosis of type A hepatitis by fecal IgA antibody against hepatitis A antigen. Gastroenterology 78:114–118
    [Google Scholar]
  32. Yotsuyanagi H., Koike K., Yasuda K., Moriya K., Shintani Y., Fujie H., Kurokawa K., Iino S. 1996; Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction. Hepatology 24:10–13 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81157-0
Loading
/content/journal/jgv/10.1099/vir.0.81157-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error